FDA approves Ipsen's Somatuline Depot for carcinoid syndrome

Ipsen Group (Euronext:IPN; Pink:IPSEY) said FDA approved Somatuline Depot

Read the full 93 word article

How to gain access

Continue reading with a
two-week free trial.